5 completed, 1 terminated. 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Terminated 1 |
Follow elesclomol: new trials by email Literature Review of elesclomol trials Research Report on elesclomol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statins, Cholesterol and Cognitive Decline in Alzheimer's STA 4783 - Alzheimer Dementia, Statins | Completed | Karolinska Institutet | 2000 | 2025-01-01 | 2025-05-02 | |
| Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Elesclomol Sodium, Paclitaxel - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 2 | Completed | GOG Foundation | 58 | 2010-12-13 | 2021-10-20 |
| Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma Elesclomol (STA-4783), Paclitaxel - Melanoma | Phase 3 | Terminated | Synta Pharmaceuticals Corp. | 630 | 2007-08-01 | 2014-03-04 |
| A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas STA-4783 - Soft Tissue Sarcoma | Phase 2 | Completed | Synta Pharmaceuticals Corp. | 80 | 2004-07-01 | 2006-06-20 |
| STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma STA-4783, Paclitaxel - Melanoma | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 103 | 2004-05-01 | 2014-03-06 |
| STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Paclitaxel, Carboplatin, STA 4783 - Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 86 | 2004-03-01 | 2008-12-04 |
Melanoma (2) · Alzheimer Disease (1) · Brenner Tumor (1) · Carcinoma, Non-Small-Cell Lung (1) · Fallopian Tube Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Sarcoma (1)
Synta Pharmaceuticals Corp. (4) · GOG Foundation (1) · Karolinska Institutet (1)
United States (5) · Canada (2) · Australia (1) · Germany (1) · Puerto Rico (1) · Romania (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Bradley J Monk (1)
U10CA027469 (1), U10CA180868 (1)